iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of Mar 21
 +0.13 / +0.12%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index- which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq- Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures- options and swap contracts- cash and cash equivalents. It is non-diversified.


1 month+1.25% 3 years-3.11%
3 months+3.79% 5 years+16.45%
1 year+12.15% Since inception+7.41%
Data through 03/21/2018

Quote Details

Previous close$110.54
Open day’s range110.21 – 111.47
Net asset value (NAV)110.58 (03/20/2018)
Daily volume1,904,082
Average volume (3 months)2,855,135
Data as of 4:00pm ET, 03/21/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+16.45%+17.28%
Expense Gross exp ratio0.47%1.30%
Risk 5 year sharpe ratio0.801.02
Net assets$9.3B$3.1B
Average market cap$15.2B$10.4B
Average P/E29.322.9
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences8.22%
AMGN Amgen8.17%
BIIB Biogen7.01%
CELG Celgene6.75%
VRTX Vertex Pharmaceuticals Inc4.49%
REGN Regeneron Pharmaceuticals4.47%
ILMN Illumina Inc3.87%
ALXN Alexion Pharmaceuticals Inc3.57%
MYL Mylan NV2.94%
INCY Incyte Corp2.44%